200 Participants Needed

Cardiac MRI for Heart Failure

(STICOS Trial)

Recruiting at 8 trial locations
MG
Overseen ByMario Gaudino, MD, PhD, MSCE, FEBCTS, FACC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if heart tissue changes visible on MRI scans can predict serious issues like heart failure or hospital readmissions after procedures such as stents or bypass surgery. It focuses on patients with heart issues, specifically those with weakened heart pumping ability and significant artery blockages, who are scheduled for these procedures. The study targets individuals with a history of heart problems, reduced heart pumping ability, and plans for heart surgery or stenting within the next three months. As an unphased trial, this study offers participants the chance to contribute to important research that could enhance future heart care.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that Cardiac Magnetic Resonance Imaging is safe for patients undergoing revascularization?

Research has shown that cardiac magnetic resonance imaging (MRI) is generally safe and well-tolerated. Many studies have found it to be a noninvasive method for detecting heart conditions, as it doesn't require surgery or entering the body.

Cardiac MRI accurately identifies heart issues without causing harm and is often used to diagnose heart diseases due to its ability to provide clear images. While any medical test can carry some risks, serious problems with cardiac MRI are rare.

Most individuals undergoing this imaging test report no major side effects. Occasionally, some may feel discomfort from lying still or from the contrast dye used during the test, but these effects are usually minor and short-lived. Overall, cardiac MRI is considered a safe option for those participating in heart studies.12345

Why are researchers excited about this trial?

Most treatments for ischemic left ventricular systolic dysfunction (iLVSD) and coronary artery disease (CAD) focus on revascularization techniques like PCI (Percutaneous Coronary Intervention) or CABG (Coronary Artery Bypass Grafting). However, this study is unique because it uses cardiac magnetic resonance (CMR) imaging both before and potentially after these procedures. Researchers are excited because CMR offers a detailed look at the heart's structure and function, which could help tailor treatments to each patient's needs and improve outcomes. By collecting long-term clinical data, the study aims to provide insights into how these imaging techniques can enhance the effectiveness of existing revascularization methods.

What evidence suggests that cardiac magnetic resonance imaging is effective for predicting postoperative cardiovascular events?

Research has shown that Cardiac Magnetic Resonance Imaging (CMR) accurately diagnoses heart conditions. One study found that CMR correctly identified heart issues 86% to 89% of the time. Another study demonstrated that CMR can detect coronary artery disease (CAD) as effectively as more invasive methods. In this trial, patients diagnosed with ischemic left ventricular systolic dysfunction (iLVSD) and CAD undergoing revascularization may use CMR to assess heart function. CMR also evaluates blood flow through the heart and checks heart tissue health, helping to identify areas at risk. This non-invasive imaging method serves as a useful tool for predicting potential heart problems after procedures like stents or bypass surgery.34567

Who Is on the Research Team?

MG

Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC

Principal Investigator

Weill Medical College of Cornell University

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.
My heart's pumping ability is reduced (LVEF ≤ 40%).
I have severe blockages in my heart's arteries.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-procedure CMR

Eligible patients undergo preoperative Cardiac Magnetic Resonance Imaging (CMR) to assess heart tissue abnormalities

1-2 weeks
1 visit (in-person)

Revascularization Procedure

Participants undergo coronary revascularization via PCI or CABG

1 day
1 visit (in-person)

Postoperative CMR

Participants may undergo postoperative CMR to assess changes in heart tissue

1-2 weeks
1 visit (in-person)

Follow-up

Participants are monitored for long-term outcomes such as heart failure, readmission, or death

5 years

What Are the Treatments Tested in This Trial?

Interventions

  • Cardiac Magnetic Resonance Imaging

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Patients diagnosed with iLVSD and CAD undergoing revascularization.Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Citations

Cardiac Magnetic Resonance Imaging in Patients with ...

Because of its superior spatial resolution and endocardial border definition, this CMR method has been shown to yield higher diagnostic accuracy (86%; 89% ...

Advanced cardiac magnetic resonance imaging for ...

The ADVOCATE-CMR study aims to validate QP CMR, ∆T1 and OS-CMR imaging against invasive fractional flow reserve (FFR) for the detection of obstructive CAD.

Diagnostic accuracy of late gadolinium enhancement ...

This large, prospective multicentre study found that rest LGE-CMR has limited sensitivity (57%) for detecting significant CAD in patients with rLVEF, indicating ...

Stress Cardiac Magnetic Resonance Myocardial Perfusion ...

Stress cardiovascular magnetic resonance imaging (CMR) is a cost-effective, noninvasive test that accurately assesses myocardial ischemia, myocardial viability ...

Cardiac MRI in Front Line for the Diagnosis of Coronary ...

This analysis aims to enhance the diagnostic accuracy of coronary artery disease (CAD) detection in patients with reduced left ventricular ejection fraction ( ...

Cardiac Magnetic Resonance Imaging in Ischemic Heart ...

Cardiac magnetic resonance imaging (MRI) has emerged as a prime player in the clinical and preclinical detection of ischemic heart disease (IHD) as well in ...

Cardiac MRI in Front Line for the Diagnosis of Coronary ...

Theo Pezel, will apply advanced AI algorithms to detect ischemic patterns and quantify myocardial scarring. This AI analysis aims to improve the sensitivity and ...